WHO ICTRP trial
A comparison of the effect of Atropine and Botulinum-toxin in patients with…
EUCTR2007-003017-14-SE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-003017-14-SE |
|---|---|
| Public title | A comparison of the effect of Atropine and Botulinum-toxin in patients with severe drooling |
| Scientific title | A comparison of the effect of Atropine and Botulinum-toxin in patients with severe drooling |
| Primary sponsor | Käkkliniken, Universitetssjukhuset i Linköping |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Patients with ALS, Parkinson´s disease, brain-damage cerebral paralysis or other neurological conditions often have an impaired swallowing, resulting in drooling. This adds a social handicap and often also causes facial dermatitis… |
| Interventions | Trade Name: Botox Product Name: Botox Product Code: M03AX01 Pharmaceutical Form: Powder for solution for injection Trade Name: Atropin Chauvin Product Name: Atropin Chauvin Product Code: S01FA01 Pharmaceutical Form: Eye drops, solution |
| Registration date | Jun 19, 2007 |
| Secondary IDs | 132998 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: